Scientists at the University of Liverpool and Callaghan Innovation in New Zealand have developed a new chemical approach to help harness the natural ability of complex sugars to treat Alzheimer's disease.
May 29, 2013
0
0
Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...
May 22, 2013
0
0
A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current ...
May 9, 2013
0
0
New research from the UC Davis Comprehensive Cancer Center, published in the Journal of Surgical Research, may help clinicians determine which patients are at highest risk for post-surgical blood clots in the legs or lungs.
Mar 20, 2013
0
0
Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots.
Mar 13, 2013
0
0
The clot-busting drug tenecteplase prevents death or circulatory collapse in a subgroup of patients with a blood clot in the lungs and appears to be especially useful in patients younger than 75, according to research presented ...
Mar 12, 2013
0
0
(Medical Xpress)—Anticoagulants have saved the lives of those at risk for heart attack or stroke. However, because they prevent blood clotting, they can be dangerous to patients who suffer traumatic injuries or who require ...
(HealthDay)—Men with advanced prostate cancer might live longer when they are taking blood-thinning medication, a small study suggests.
Feb 21, 2013
0
0
(Medical Xpress)—In "before" and "after" photos from advertisements for wound-healing ointments, bandages and antibiotic creams, we see an injury transformed from an inflamed red gash to smooth and flawless skin.
Feb 20, 2013
2
0
(HealthDay)—Anticoagulant use is associated with improved overall survival in men receiving docetaxel chemotherapy for treatment of metastatic castration-resistant prostate cancer (mCRPC), according to research presented ...
Feb 19, 2013
0
0
